Table 3. Multivariate Survival Analysis of OS and DFS in 68 patients with HCC.
Variables | OS | DFS | ||||
RR | 95%CI | Pa | RR | 95%CI | Pa | |
TNM stage | 2.482 | (1.003–6.143) | 0.049 | 1.905 | (0.868–4.181) | 0.108 |
Portal vein invasion | 3.542 | (1.752–7.158) | <0.001 | 2.953 | (1.437–6.068) | 0.003 |
Histopathological differentiation | 1.325 | (0.861–2.037) | 0.200 | 1.336 | (0.888–2.010) | 0.165 |
LAPTM4B genotype | 3.147 | (1.619–6.115) | 0.001 | 2.729 | (1.427–5.220) | 0.002 |
LAPTM4B, Lysosomal protein transmembrane 4 beta; HCC, hepatocellular carcinoma; OS, overall survival; DFS, disease-free survival; RR, relative risk; CI, confidence interval; a,Cox regression test.